SCHEMBL19081932

SCHEMBL19081932

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5ccc7oc8c9ccccc9ccc8c7c56)cc4)c4ccccc34)cccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 11/20 0.33
CYP1B1 Q16678 11/20 0.33
IKBKB O14920 1/20 0.33
CYP1A2 P05177 10/20 0.32
PRKDC P78527 3/20 0.32
CYP3A4 P08684 2/20 0.32
TSHR P16473 2/20 0.32
CYP2C19 P33261 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32
PSMD14 O00487 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
XDH P47989 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081953 0.95 CYP1A1 (0.33) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19082060 0.95 CYP1A1 (0.37) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19076693 0.93 BRDT (0.32) CYP1A1CYP1B1IKBKB
SCHEMBL19082039 0.93 ARSA (0.34) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19081897 0.91 CYP1A1 (0.39) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19081913 0.89 CYP1A1 (0.38) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19081975 0.89 CYP1A1 (0.41) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19082054 0.89 CYP1A1 (0.37) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19081946 0.89 CYP1A1 (0.33) CYP1A1CYP1B1IKBKBCYP1A2PRKDC
SCHEMBL19081781 0.88 CYP1A1 (0.40) CYP1A1CYP1B1IKBKBCYP1A2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885IKBKB 3678/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885IKBKB 3678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.